DWTX: Dogwood Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.97
Enterprise Value ($M) 79.91
Book Value ($M) 64.28
Book Value / Share 48.25
Price / Book 0.08
NCAV ($M) -13.48
NCAV / Share -10.12
Price / NCAV -0.37

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -3.83
Return on Equity (ROE) -3.24

Liquidity (mrq)
Quick Ratio 5.21
Current Ratio 5.21

Balance Sheet (mrq) ($M)
Current Assets 16.54
Assets 94.31
Liabilities 30.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -12.23
Net Income -12.35

Cash Flow Statement (mra) ($M)
Cash From Operations -8.79
Cash from Investing 3.76
Cash from Financing 16.70

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-17 13G Orca Capital AG 6.10
03-17 13D/A Sealbond Ltd 15.90 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 707,706 1,960,511 36.10
2025-04-16 164,884 616,187 26.76
2025-04-15 6,785,481 19,828,887 34.22
2025-04-14 40,935 127,964 31.99

(click for more detail)

Similar Companies
DRRX – DURECT Corporation DRUG – Bright Minds Biosciences Inc.
DTIL – Precision BioSciences, Inc. DYAI – Dyadic International, Inc.
EDSA – Edesa Biotech, Inc.


Financial data and stock pages provided by
Fintel.io